Lilly Buys Vaccine Makers
Eli Lilly acquires three vaccine makers for nearly $4 billion, expanding its vaccine portfolio. The move marks a significant push into the vaccine market for the drugmaker.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Lilly Buys Vaccine Makers
Eli Lilly acquires three vaccine developers to expand its portfolio. The deal is worth $3.8 billion.